After in Biological Technology

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009, after the close of U.S.-based financial markets. Howard Robin, president and chief execut...

Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose

QUEBEC CITY, July 30 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has achieved additional positive ...

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration

SCOTTSDALE, Ariz., July 29 /PRNewswire-FirstCall/ -- ImmuneRegen BioSciences(R), a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC Bulletin Board: IRBS), reports preliminary evidence that its selective Neurokinin 1-receptor agonist Homspera(R) is both active on ora...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

PHILADELPHIA, July 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-dai...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

VYVANSE is the first stimulant to establish duration of efficacy from two hours up to 14 hours after administration in adults with ADHD HOLLYWOOD, Fla., July 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced res...

BASF Podcast: The Chemical Reporter - Why Does Your Urine Smell so Different After You've Eaten Asparagus?

LUDWIGSHAFEN, Germany, June 10 /PRNewswire/ -- It doesn't take long after you've polished off a plateful of the delicious vegetable before you are forcefully reminded of it in the restroom. Some people are surprised by the strange odor rising from the bowl after urinating. The unmistakable olf...

Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes

Conference Call Scheduled for 5:00 p.m. ET ORANGE COUNTY, Calif., April 13 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today it will host a conference call on Tuesday, April 28, 2009, at 5:00 p.m. ET to discuss the company's first quarter 2009 results. Earnings w...

Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting

KVISTGAARD, Denmark, March 3 /PRNewswire-FirstCall/ -- Following the completion of the Phase II clinical development of IMVAMUNE(R), a third-generation smallpox vaccine, Bavarian Nordic has held an end of Phase II meeting with the FDA to discuss the Phase III development. The meeting was a suc...

Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the fourth quarter and year ended December 31, 2008 on Wednesday, February 25, 2009, after the close of U.S.-based financial markets. Howard Robin, president and...

Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

VALLEY COTTAGE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today provided notification that on February 3, 2009 the Company received a letter from a shareholder who owns more than 5% of the Company's outstanding ordinary shares requesting th...

XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

VALLEY COTTAGE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) today provided notification that on February 3, 2009 the Company received a letter from a shareholder who owns more than 5% of the Company's outstanding ordinary shares requesting th...

Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes

Conference Call Scheduled for 5:00 p.m. ET ORANGE COUNTY, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today it will host a conference call on Monday, February 9, 2009, at 5:00 p.m. ET to discuss the company's fourth quarter and full year 20...

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV ) today announced top-line results showing that the Phase 3 trial evaluating Adlea(TM), its long-acting, non-opioid analgesic drug candidate, achieved its primary efficacy endpoint of reducing post-surgica...

Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities

KVISTGARD, Denmark, November 19 /PRNewswire-FirstCall/ -- Bavarian Nordic has invoiced the U.S. authorities for another milestone payment of USD 25 million as allowed under the RFP-3 contract to manufacture and deliver 20 million doses of the company's IMVAMUNE(R) smallpox vaccine. This milest...

China Clean Energy Resumes Biodiesel Production After Temporary Halt

FUQING CITY, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China Clean Energy Inc. (OTC Bulletin Board: CCGY) ("China Clean Energy", the "Company") today announced that, as of November 10, 2008 it has resumed biodiesel production. China Clean Energy decided to resume biodiesel production a...

Persistent Vaccination Effect of GRAZAX(R) After Completion of Treatment

COPENHAGEN, October 22 /PRNewswire-FirstCall/ -- Breakthrough: Results from the fourth year in a long-term clinical study prove the disease modifying effect of GRAZAX(R). For the first time ever, it is documented that the positive clinical effect of the tablet vaccine persists after completion...

Amoena Helps Women Re-shape Their Lives After Breast Cancer Surgery

Surprisingly, a high percentage of women aren't aware of the advanced products that can help restore a positive body image ATLANTA, Oct. 16 /PRNewswire/ -- Women have more options than ever before when facing breast cancer. With early diagnosis, great strides have been made in treatm...

SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND

TSX symbol: SBS CALGARY, Sept. 16 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it is eligible to proceed with its planned Phase I/II human cli...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

- Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings - Historically, one in two patients experienced recurrence of GIST after surg...

Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., July 30 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter ended June 30, 2008 on Wednesday, August 6, 2008, after the close of U.S.-based financial markets. Howard Robin, president and chief executive o...

18-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto

SEATTLE, July 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that Congress today passed the Medicare Improvements for Patients and Providers Act of 2008, which includes an 18-month extension of the 2007 reimbursement rate for radioimmunotherapies su...

Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass

Studies Presented at American Society for Metabolic and Bariatric Surgery Meeting SAN CLEMENTE, Calif., June 23 /PRNewswire/ -- USGI Medical Inc. (USGI) announced today that leading experts presented clinical evidence showing that its EndoSurgical Operating System...

Iowa Resident Dies After Using Contaminated Blood Thinner

Illinois Pharmaceutical Manufacturer Named In Lawsuit CHICAGO, May 14 /PRNewswire/ -- Last month a lawsuit was filed against Deerfield, Illinois-based Baxter International Inc. on behalf of Davenport, Iowa resident, Mark Scott who suffered the tragic loss of his wife, Melissa Scott, o...

Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets

SAN CARLOS, Calif., April 30 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the first quarter ended March 31, 2008 on Wednesday, May 7, 2008, after the close of U.S.-based financial markets. Howard Robin, president and chief executive off...

Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.

NEENAH, Wis., March 25 /PRNewswire-FirstCall/ -- Plexus Corp. (Nasdaq: PLXS), today announced it will release its fiscal 2008 second quarter results for the period ended March 29, 2008 on Wednesday, April 23rd after the stock market closes. Senior management will host a live webcast and confer...

Elusys' Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection

Single, Intramuscular (IM) Dose, Protects up to 75 Percent in Primate Study PINE BROOK, N.J., April 22 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, tod...

Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.

NEENAH, Wis., March 25 /PRNewswire-FirstCall/ -- Plexus Corp. (Nasdaq: PLXS), today announced it will release its fiscal 2008 second quarter results for the period ended March 29, 2008 on Wednesday, April 23rd after the stock market closes. Senior management will host a live webcast and confer...

PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents

WASHINGTON, Dec. 13 /PRNewswire/ -- Patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing drug clopidogrel for at least one year, and possibly longer, after stent implantation. This is a crucial message in a guideline update published online today i...

Jack Anthony to Resign From VaxGen's Board After Accepting CEO Position at Osprey Pharmaceuticals

SOUTH SAN FRANCISCO, Calif., Sept. 28 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN) announced today that Jack Anthony has resigned from the company's Board of Directors as a result of accepting the CEO position at Osprey Pharmaceuticals. The Osprey Board has required that Mr. Anth...

The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes

AMSTERDAM, September 19 /PRNewswire/ -- - IDF Launches New Guideline for the Management of Postmeal Glucose IDF today issued the new global guideline for diabetes care which includes the management of postmeal glucose.(1) The guideline emphasizes that people with diabetes should have their b...

Sound Focus plans to enter home-entertainment market after taking Governor's prize

Sound Focus has a plan: rework home entertainment with a speaker system that can project different sounds to different places without complicated acoustic engineering. That plan won top honors in the information technology category at Wisconsin Gov. Jim Doyle's first annual business-plan contest...

One year after the 2003 blackout: Is Wisconsin prepared?

On Aug. 13 and 14, 2003, the United States was hit with the largest blackout in its history. Wild power surges and transmission failures exposed holes in the grid that were previously unknown. Its business as usual for Wisconsin power companies, now that preparing for a similar disaster has been ...

Why you should never name your company after a fruit

A very serious fight between Apple Computers and Apple Records (of Beatles fame) is now headed for the ninth round. On this side of the ring is Sir Paul McCartney, with the title of a legendary musical artist and boyish looks with a cute smile. On the other side, yet another youthful boy wonde...

Third Wave to seek FDA clearences after expanding pipeline

Madison, Wis. Third Wave Technologies has expanded its product pipeline and will seek FDA clearance for several products within the next few years, the company told investors and analysts on Thursday. Third Wave, based in Madison, makes molecular genetic diagnostics. The company said revenu...

Reading Tommy Thompson's mind – life after public service

Reading Tommy Thomsons mind: Now what? Everyone thinks I have some cushy job lined up now that I've decided to quit as secretary at the Department of Health and Human Services, but they couldn't be further from the truth. Most people don't realize that federal ethics rules basically keep ...

Criticare narrows loss, but sales drop after partner is bought

Milwaukee Criticare Systems Inc., which makes clinical patient monitors and sensors, reported a net loss of $245,000 for the quarter that ended March 31, on sales of $6 million. Sales were down from nearly $6.6 million in the same quarter of 2004, but operating expenses were also down, and th...

UW System says goodbye to Lawson after 5 years, $26 million

Madison, Wis. - The decision by University of Wisconsin System to discontinue implementation of a system-wide payroll and benefit system with Lawson Software , and go with Oracle / PeopleSoft payroll and benefit software, came as no surprise. What surprised many was that it took so long -...

Rexnord to slash debt after quarterly loss

Milwaukee, Wis. - Following a quarterly net loss of $2.8 million, executive officers at Rexnord Corp. , a manufacturer of motion technology products, said the company is focused on reducing its debt. In a report of first quarter 2007 results, CFO Tom Jansen highlighted increased quarterly sal...

JT Packard exec resigns after settling copyright disputes

Madison, Wis. - Following a devastating legal rebuke, the chief executive of JT Packard has left the company he founded to pursue other business interests. Jeff Cason, who had served as president of the Verona-based provider of uninterruptible power supply services, resigned after settling t...

NimbleGen to discontinue IPO after Roche's $272.5 million acquisition

Madison, Wis. - NimbleGen Systems , a manufacturer of gene chips for pharmaceutical research, will discontinue its work toward an initial public offering of stock following its acquisition by Roche , the Basel, Switzerland based pharmaceutical giant. NimbleGen had sought to raise $75 million...